Rami Hannoush is a venture partner operating across San Diego and the San Francisco Bay Area. He brings a unique blend of investment experience and deep drug discovery expertise to our company creation efforts.

Rami most recently served as a general partner at Mubadala Capital, building the firm’s healthcare platform in the U.S. and investing in early stage life science companies. He also was a co-founder and CEO of EpiBiologics.

Prior to that, Rami was an accomplished and respected member of the Genentech R&D team for a period of more than 16 years. His leadership roles included area head for new therapeutic modalities and group leader for a multitude of successful programs in the fields of oncology and immunology.

• 

  Venture Partner in Versant Ventures

  HARNESSING THE POWER OF SCIENCE, GLOBALLY